# Increased expression of Toll-like receptors and associated alarmins in temporal arteries of patients with giant cell arteritis

**Authors:** S. Seidlberger, M. Schirmer, G. Wietzorrek, J. A. Jiménez-Heffernan, M. Pardines, M. de las Fuentes Monreal, M. A. González-Gay, S. Castañeda, S. Santos-Sierra

PMC · DOI: 10.1186/s10020-025-01390-4 · Molecular Medicine · 2025-11-12

## TL;DR

This study finds that Toll-like receptors and alarmins are overexpressed in the arteries of patients with giant cell arteritis, especially in the cranial type, and may serve as potential biomarkers.

## Contribution

The study provides the first evidence of TLR and alarmin expression patterns in different GCA subtypes and their association with inflammatory markers.

## Key findings

- TLR2/4/7/8 and alarmins HMGB-1, SAA, and fibrinogen are highly increased in cranial GCA arteries.
- Plasma levels of SAA and fibrinogen correlate strongly with CRP and ESR in GCA patients.
- Glucocorticoids and TAK1-inhibitors reduce SAA- and fibrinogen-mediated IL-6 production in control cells.

## Abstract

Giant cell arteritis (GCA) is a chronic granulomatous inflammatory disease involving large- and medium-sized arteries. The disease spectrum comprises cranial (C-GCA), extracranial (EC-GCA) and mixed phenotypes. Toll-like receptors (TLRs) in the affected arteries may play an important role in GCA pathogenesis. However, data on TLR and TLR-ligands expression pattern in GCA arteries are lacking.

To investigate the expression of TLRs and putative ligands in temporal artery biopsies (TAB) from C-GCA, EC-GCA and isolated polymyalgia rheumatica (PMR) patients to establish a link between TLRs, antigen expression, and disease stage. To correlate the plasma levels of identified TLR-ligands with standard inflammatory markers (IL-6, CRP, ESR) in these patients.

Immunofluorescence staining of TLR2/4/7/8, HMGB-1, SAA, fibrinogen, and p-glycoprotein was performed with TABs of six biopsy proven C-GCA, six EC-GCA, five PMR patients and seven age-matched controls. Association studies among plasma inflammatory markers were done with 139 PMR and 40 GCA patients.

The levels of TLR2/4/7/8 and the alarmins HMGB-1, SAA, and fibrinogen were highly increased in C-GCA TABs in the sites of inflammation and less in EC-GCA TABs. P-glycoprotein was overexpressed in C-GCA TABs. Glucocorticoids or TAK1-inhibitor treatment decreased the fibrinogen- and SAA-mediated IL-6 production in control PBMCs. Plasma levels of SAA and fibrinogen associated strongly with CRP and ESR levels.

TLRs are overexpressed at the site of vascular inflammation in C-GCA and at a lower level in EC-GCA and PMR with negative TAB. Moreover, HMGB-1, SAA, and fibrinogen may serve as disease biomarkers of patients with C-GCA.

The online version contains supplementary material available at 10.1186/s10020-025-01390-4.

## Linked entities

- **Proteins:** TLR2 (toll like receptor 2), TLR4 (toll like receptor 4), TLR7 (toll like receptor 7), TLR8 (toll like receptor 8), HMGB1 (high mobility group box 1), SAA1 (serum amyloid A1), FGB (fibrinogen beta chain), Mdr65 (Multi drug resistance 65), IL6 (interleukin 6)
- **Chemicals:** TAK1-inhibitor (PubChem CID 66760355)
- **Diseases:** giant cell arteritis (MONDO:0008538), polymyalgia rheumatica (MONDO:0019735)

## Full-text entities

- **Genes:** HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, SAA [NCBI Gene 6287], CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MAP3K7 (mitogen-activated protein kinase kinase kinase 7) [NCBI Gene 6885] {aka CSCF, FMD2, MEKK7, TAK1, TGF1a}
- **Diseases:** C-GCA (MESH:D013700), PMR (MESH:D011111), granulomatous (MESH:D013968), inflammation (MESH:D007249)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12613359/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12613359/full.md

---
Source: https://tomesphere.com/paper/PMC12613359